Researchspacemetadata only
Repositioning FDA-approved drugs to identify potential mycobacterial FadD23 inhibitors.
fda., m. tuberculosis., drug repositioning., molecular dynamics simulation., fadd23.
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 309646
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.